Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19 – CNBC
Posted: June 18, 2020 at 7:57 am
Tempus, a Chicago-based technology company that offers genetic testing and aggregates clinical information, initially focused on cancer patients. But with the coronavirus pandemic spreading across the world, it's joining the fight against Covid-19.
Tempus was founded in 2015 by its CEO, Eric Lefkofsky, who previously co-founded the e-commerce company Groupon in 2008. But while Tempus' mission may seem far removed from that of an online discount marketplace, Lefkofsky had personal reasons for branching out.
"My wife was diagnosed with breast cancer about five years ago, and I was amazed how little data was actually used as a part of her therapy, largely because our system makes it hard for doctors to access data when making real-time clinical decisions," he said. "It became clear to me that I needed to try and tackle this problem, and I founded Tempus soon afterwards."
Tempus, which ranked No. 6 on the 2020 CNBC Disruptor 50 list, has three primary lines of business. It offers genomic tests that physicians can order, its most popular being a test that looks for over 600 genes associated with cancer. (It does not offer any direct-to-consumer genetic testing, like a 23andMe.)
After Groupon co-founder Eric Lefkofsky's wife was diagnosed with breast cancer, he discovered how hard the U.S. health system makes it for doctors to access data in clinical decision-making. That led him to found disease-agnostic AI start-up Tempus, which is now mining patient data for a potential Covid-19 medicine.
Tempus
It also partners with academic medical centers and community health-care systems to organize and aggregate clinical data, primarily data held in electronic health records. The clinical data is de-identified to protect patient privacy, then typically used in research projects to help understand patterns. Tempus claims to have one of the largest molecular and clinical data libraries.
There is crossover between these two businesses, as data from genomic tests that run in its Chicago and Atlanta labs can be de-identified and added to the molecular and clinical data library.
Finally, it curates and sells de-identified data to pharmaceutical companies working on drug discovery.
Tempus is a covered entity under the Health Insurance Portability and Accountability Act (HIPAA), so all of the datais scrubbed of patient name, date of birth, address and any other data point that could identify an individual.
Early on, Lefkofsky felt that the Tempus platform should apply to a broad cross-section of patient data. For this reason the Tempus platform was designed to be what the company calls "disease agnostic," which means it can be applied to patients suffering from many kinds of illnesses, including cancer, depression, diabetes, cardiovascular disease and Covid-19.
In April, Tempus began offering a polymerase chain reaction (PCR) test for Covid-19 from its Chicago and Atlanta laboratories. It currently expects to build its testing capacity to approximately 10,000 tests a day in the coming months. The test, offered through physicians, was rolled out parallel to the start of a research project to gather data on Covid-19 patients and look for patterns that can help physicians treating patients as well as drug-discovery efforts. Procedures may vary from patient to patient, but this is where Lefkofsky thinks the company's AI platform can do the most good.
"We are focused on collecting real-world evidence for patients that are Covid-19 positive to help doctors stratify patients based on risk and help triage patients to the optimal therapeutic path for them, based on their unique phenotypic characteristics," he said.
Dr. Scott Gottlieb, resident fellow at the American Enterprise Institute and special partner at New Enterprise Associates, sits on Tempus' board of directors. He joined after serving as commissioner of the Food and Drug Administration, where he spearheaded efforts to advance the use of artificial intelligence to create individualized patient care.
"I was impressed by the company's ability to rapidly scale its sequencing operations to support major academic institutions and community oncologists across the country and get data to patients and providers," he said. "They were focused not only on the back-end technologies to enable these opportunities, but equally important the front-end interfaces to make this information useful at the point of care."
Artificial intelligence could help us solve a number of serious public health problems and improve outcomes for patients with infectious diseases.
Scott Gottlieb
former FDA commissioner and Tempus board member
It also launched an initiative whose goal is to aggregate data for 50,000 patients who are Covid-19-positive. The hope is that this data will help reveal genetic characteristics that cause specific Covid-19 outcomes, as well as treatment practices for the illness.
Gottlieb added that Tempus is partnering with employers and health-care providers to support Covid-19 testing in states where restrictions are being relaxed, and employees are going back to work, so they'll know what to watch out for.
"We're going to have to be more aggressive in detecting and identifying respiratory viruses," he said. "To these ends, Tempus is also working on a next-generation sequencing panel for respiratory pathogens, including Covid-19, to diagnose patients and create a library for infectious disease research that could reduce the impact of future epidemics."
While Tempus' use of health data as a way to accelerate research shows promise, there are limitations.
Dr. Jose Morey, Chief Medical Innovation Officer for Liberty BioSecurity and advisor for MIT Solve and NASA iTech, said that one problem in relying on AI in the case of a new virus is that there isn't enough data at the moment.
"You have to have large data sets to be able to train, test, and validate," he said. "When you have something new and novel like this, they just don't exist. ... It will come eventually, but not yet."
More from Disruptor 50:Meet the 2020 CNBC Disruptor 50 companiesThe technology that will dominate daily life on the other side of coronavirusOpportunity Missed: Why there are no Black CEOs on this year's list
He added that the technology is also only as good as the data, and currently, there are systemic flaws in the way medical data is gathered and recorded. For example, he said that data in medical centers could be "dirty."
"This means that the data is not structured to be plugged into the math that is AI,'" he said. He added that health-care data is also frequently "siloed," or separated into unconnected compartments. For AI to do its job, it requires large amounts of interconnected data, which Morey said doesn't exist in the U.S. health-care system.
"Health-care entities, such as device manufacturers, electronic medical record vendors, and hospitals, are not incentivized to share data amongst each other," he said. "This is why there are so many AI companies doing incremental algorithm and application development."
In April, Tempus began offering a polymerase chain reaction (PCR) test from its Chicago and Atlanta laboratories. It expects to build its testing capacity to 10,000 tests a day in the coming months and hopes to aggregate data for 50,000 patients who are Covid-19-positive.
Tempus
While this is a challenging moment for the U.S. health-care system, Tempus has been recognized by the medical community and investors as a company whose platform shows great promise.
The company has raised $620 million from investors such as Baillie Gifford, Franklin Resourcesand T. Rowe Price,and is valued at $5 billion. It has also entered into a partnership with CVS Health, which allows oncologists in the CVS Health/Aetna network to use the results of its genomic sequencing tests.
Covid-19 research, like cancer research, has yet to yield a cure. However, Gottlieb said that he sees AI tools as indispensable for cancer patients, infectious disease patients and others in the future.
"As we collect more data and apply AI tools to large datasets, we can direct care to patients at greatest risk," he said. "Artificial intelligence could help us solve a number of serious public health problems and improve outcomes for patients with infectious diseases."
Correction: Tempus has raised $620 million from investors at a valuation of $5 billion. An earlier version of this article misstated the fundraising amount.
Disclosure: Scott Gottlieb is a CNBC contributor.
Original post:
Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19 - CNBC
- A New Price Tag for Breast Cancer Genetic Testing - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Genetic testing technologies - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Prostate Cancer Genetic testing - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Genetic Testing - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Genetic Testing - One of the Best Things to Happen to Me - littlemamauk - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- BowelGene - genetic testing - Video [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Genetic Testing Fact Sheet - National Cancer Institute [Last Updated On: May 22nd, 2015] [Originally Added On: May 22nd, 2015]
- Genetic Testing - Genetics Home Reference [Last Updated On: May 22nd, 2015] [Originally Added On: May 22nd, 2015]
- FAQ About Genetic Testing - Genome.gov [Last Updated On: May 31st, 2015] [Originally Added On: May 31st, 2015]
- Regulation of Genetic Tests [Last Updated On: June 9th, 2015] [Originally Added On: June 9th, 2015]
- Types of Genetic Testing - Genetics Home Reference [Last Updated On: June 29th, 2015] [Originally Added On: June 29th, 2015]
- Genetic Testing: What You Should Know - FamilyDoctor.org [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- Genetic Testing - BRCA1 & BRCA2 Mutations | Susan G. Komen [Last Updated On: July 6th, 2015] [Originally Added On: July 6th, 2015]
- What is genetic testing? - Genetics Home Reference [Last Updated On: July 6th, 2015] [Originally Added On: July 6th, 2015]
- Genomics |Genetic Testing [Last Updated On: August 24th, 2015] [Originally Added On: August 24th, 2015]
- What is genetic testing? - American Cancer Society [Last Updated On: August 24th, 2015] [Originally Added On: August 24th, 2015]
- Genetic testing - WebMD [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Genetic Testing and Screening | Florida Hospital [Last Updated On: September 2nd, 2015] [Originally Added On: September 2nd, 2015]
- Genetic Testing Toledo OH - DNA Diagnostics Center [Last Updated On: September 29th, 2015] [Originally Added On: September 29th, 2015]
- Genetics - Genetic testing and counselling - NHS Choices [Last Updated On: October 25th, 2015] [Originally Added On: October 25th, 2015]
- Genetic Testing Germantown MD - DNA Diagnostics Center [Last Updated On: February 18th, 2016] [Originally Added On: February 18th, 2016]
- GeneDx | Genetic Testing Company | The DNA Diagnostic Experts [Last Updated On: February 18th, 2016] [Originally Added On: February 18th, 2016]
- Genetic Testing - kidshealth.org [Last Updated On: February 24th, 2016] [Originally Added On: February 24th, 2016]
- BRCA1 and BRCA2: Cancer Risk and Genetic Testing [Last Updated On: February 29th, 2016] [Originally Added On: February 29th, 2016]
- Genetic Testing - Breastcancer.org - Breast Cancer ... [Last Updated On: April 4th, 2016] [Originally Added On: April 4th, 2016]
- Frequently Asked Questions About Genetic Testing - Genome.gov [Last Updated On: April 10th, 2016] [Originally Added On: April 10th, 2016]
- Pregnancy & Prenatal Testing: Genetic Testing for Inherited ... [Last Updated On: April 19th, 2016] [Originally Added On: April 19th, 2016]
- Genetic Testing | Family Caregiver Alliance [Last Updated On: April 19th, 2016] [Originally Added On: April 19th, 2016]
- Genetic Testing - American Medical Association [Last Updated On: April 19th, 2016] [Originally Added On: April 19th, 2016]
- Genetic Testing - Cancer Treatment | CTCA [Last Updated On: April 19th, 2016] [Originally Added On: April 19th, 2016]
- genome.gov - FAQ About Genetic Testing [Last Updated On: April 27th, 2016] [Originally Added On: April 27th, 2016]
- Family Cancer Genetics Program at UC San Diego Moores ... [Last Updated On: May 2nd, 2016] [Originally Added On: May 2nd, 2016]
- Genetic Testing - Benefits, costs, and risks of genetic testing [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Myriad Genetics | Healthcare Professionals | About Genetic ... [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Genetic Testing | Gluten-Free Society [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Genetic testing - Canadian Cancer Society [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Genetic Testing and Molecular Biomarkers [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- genetic testing | Britannica.com [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Genetic Testing: Best Defense Against Breast Cancer? [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Genetic Testing | Issue List [Last Updated On: May 13th, 2016] [Originally Added On: May 13th, 2016]
- Jewish Genetics, Part 1: Jewish Populations (Ashkenazim ... [Last Updated On: June 19th, 2016] [Originally Added On: June 19th, 2016]
- What Is Genetic Testing -- Information About Genetic Testing [Last Updated On: June 23rd, 2016] [Originally Added On: June 23rd, 2016]
- Genetic Testing Report - genome.gov [Last Updated On: June 23rd, 2016] [Originally Added On: June 23rd, 2016]
- Good Laboratory Practices for Molecular Genetic Testing ... [Last Updated On: June 26th, 2016] [Originally Added On: June 26th, 2016]
- Genetics and Cancer | American Cancer Society [Last Updated On: July 18th, 2016] [Originally Added On: July 18th, 2016]
- Genetic testing - FSH Society [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- Myriad Genetics | Patients & Families | Genetic Testing 101 [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet ... [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- FAQ About Genetic Testing - National Human Genome Research ... [Last Updated On: September 22nd, 2016] [Originally Added On: September 22nd, 2016]
- Genetic testing - Wikipedia [Last Updated On: November 1st, 2016] [Originally Added On: November 1st, 2016]
- Genetic Testing for Cancer Risk | Cancer.Net [Last Updated On: November 25th, 2016] [Originally Added On: November 25th, 2016]
- Cancer Genetics Risk Assessment and Counseling (PDQ ... [Last Updated On: December 20th, 2016] [Originally Added On: December 20th, 2016]
- Patients Who Tested Positive For Genetic Mutations Fear Bias ... - NPR - NPR [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Genetic Testing for the Healthy - Harvard Medical School (registration) [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- Genetic testing Overview - Mayo Clinic [Last Updated On: July 1st, 2017] [Originally Added On: July 1st, 2017]
- The real reason why all women should get their DNA tested - Quartz [Last Updated On: July 4th, 2017] [Originally Added On: July 4th, 2017]
- DNA insurance: Why genetic testing could revolutionise the industry - Verdict [Last Updated On: July 4th, 2017] [Originally Added On: July 4th, 2017]
- Everything you need to know about the Government plan for genetic testing to treat cancer patients - BreakingNews.ie [Last Updated On: July 4th, 2017] [Originally Added On: July 4th, 2017]
- Greater access to genetic testing needed for cancer diagnosis and treatment - Cancer Research UK [Last Updated On: July 5th, 2017] [Originally Added On: July 5th, 2017]
- Chief medical officer calls for gene testing revolution - BBC News - BBC News [Last Updated On: July 5th, 2017] [Originally Added On: July 5th, 2017]
- Genetic Testing Facilities and Cost - Breastcancer.org [Last Updated On: July 5th, 2017] [Originally Added On: July 5th, 2017]
- Greater access to genetic testing needed for cancer diagnosis and ... - Medical Xpress [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Global Breast Cancer Predictive Genetic Testing Market Outlook 2022 - PR Newswire (press release) [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Invitae: Growth in Genetic Testing - Moneyshow.com (registration) [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Cystic Fibrosis Among Asians: Why Ethnicity-Based Genetic Testing is Obsolete - PLoS Blogs (blog) [Last Updated On: July 7th, 2017] [Originally Added On: July 7th, 2017]
- Hospital gets cardiac genetic test service created in memory of broadcaster's son - Belfast Telegraph [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- David Frost cardiac genetic testing service opens - BBC News - BBC News [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- UK's chief medical officer calls for gene testing revolution in cancer treatment - Daily Nation [Last Updated On: July 8th, 2017] [Originally Added On: July 8th, 2017]
- Konica Minolta buys US genetic test maker in $1B deal - BioPharma Dive [Last Updated On: July 10th, 2017] [Originally Added On: July 10th, 2017]
- Checking the cost of a genetic test - Chicago Tribune - Chicago Tribune [Last Updated On: July 11th, 2017] [Originally Added On: July 11th, 2017]
- Genomic Testing in Oncology: From Single Genes to Whole Genomes - Labiotech.eu (blog) [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- Direct-To-Consumer Genetic Testing Can Be a Trip Down the Rabbit Hole - Newswise (press release) [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- DNA Diagnostics Center brings four genetic testing options to retail - Drug Store News [Last Updated On: July 12th, 2017] [Originally Added On: July 12th, 2017]
- Jeans for Genes Day stall at Taree City Centre - Gloucester Advocate [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- She thought she was Irish until a DNA test opened a 100-year-old mystery - Chicago Tribune [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- Genetic testing: The new way to identify and train elite athletes? - USA TODAY High School Sports [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- Mail order genetic tests for health risks. How much do you want to ... - KOMO News [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- Genetic Testing: Finding the cause of your infertility ... [Last Updated On: July 31st, 2017] [Originally Added On: July 31st, 2017]
- SF's Invitae to acquire two prenatal genetic screening firms - SFGate [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]
- For Indian doctors, it's written in the genes not stars - Economic Times [Last Updated On: August 1st, 2017] [Originally Added On: August 1st, 2017]